Medicine News and Research

RSS

Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer trial

Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.

13 Dec 2010

EU, India leaders meet to discuss trade deal, some concerned deal will jeopardize drug access in developing countries

On Friday, Indian Commerce Minister Anand Sharma and EU Trade Commissioner Karel de Gucht met to "present a status report on the ongoing free trade talks" that some health advocates fear could limit the supply of generic medications in developing countries, according to Business Standard. "An EU source said the report would signal that talks had made excellent progress and should be wrapped up by early next year," according to the news service (Aiyar, 12/10).

13 Dec 2010

Denosumab delays skeletal-related side effects in patients with breast cancer and bone metastases

For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

13 Dec 2010

Cesarean-section deliveries may lead to degenerative back disease

Researchers from Michigan State University are studying whether pregnancies, specifically cesarean-section deliveries, are linked to a degenerative back disease that affects women three to nine times more often than men.

13 Dec 2010

Mayo clinic creates new computerized radiation tracking system

Mayo Clinic is initiating a new imaging exam tracking system that, among other things, enables a comprehensive view of a patient's radiation exposures over time.

13 Dec 2010

Genetic changes in HDAC9 gene may modulate onset of ER positive breast cancer and its recurrence

Investigators at The Cancer Institute of New Jersey have presented new research at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. Their work highlights how a variation in a person's DNA sequence is associated with an earlier age of onset for breast cancer that is stimulated by the hormone estrogen (estrogen receptor positive).

13 Dec 2010

Depression drug appears effective in reducing pain associated with breast cancer treatment

A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer Center.

12 Dec 2010

New challenges to FDA's 'no risk' classification of mercury fillings

FDA Device Division, still concerned about mercury toxicity in American dentistry, is convening yet another professional panel review regarding safety issues. A nationwide convergence of scientists, dental and medical professionals, lead by the International Academy of Oral Medicine and Toxicology (IAOMT) are provoking new challenges to the Food and Drug Administration's (FDA) July'09 "no risk" classification of mercury fillings .

10 Dec 2010

Research roundup: For-profit hospitals' readmission rate, containing self-referrals, children's dental health, revisiting McAllen

For-Profit Hospital Status And Rehospitalizations At Different Hospitals: An Analysis of Medicare Data - "Rehospitalization within the first 30 days of discharge affects 1 in 5 hospitalized Medicare fee-for-service patients and costs approximately $17.4 billion in payments annually ... the top 4 factors most related to the risk for rehospitalization at a different facility were initial admission to a for-profit index hospital … lower-volume index hospital (hospitals with <1000 annual discharges) … hospital with a major medical school affiliation … and being disabled."

10 Dec 2010

Deals, expansions and ACOs mark hospital sector activity

Hospitals and health systems are the subject of proposed deals and acquisitions. Meanwhile, the concept of accountable care organizations continues to trigger interest and curiosity within the health care sector.

10 Dec 2010

Stroke falls from third to fourth leading cause of death

A new report, "Deaths: Preliminary Data for 2008," released by the Centers for Disease Control and Prevention (CDC), says that for the first time in 50 years, stroke has fallen from the third to the fourth leading cause of death.

10 Dec 2010

Weightlifting may help prevent lymphedema following breast cancer treatment

Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team's previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment.

10 Dec 2010

Ipilimumab in combination with paclitaxel/carboplatin for stage IIIb/IV NSCLC shows superior results

Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin alone, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.

10 Dec 2010

HRT with estrogen alone may reduce risk of breast cancer: Study

While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk, according to study results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

10 Dec 2010

First Edition: December 10, 2010

In today's health policy headlines, reports about the Obama administration lawyer charged with defending the health law as well as the latest action in this lame duck Congress.

10 Dec 2010

Process of activating helicopter EMS delays treatment for heart attacks beyond recommended times

Helicopter emergency medical services can be a life saver for patients needing immediate care. But, according to a University of Cincinnati study, the process of activating them often delays treatment beyond recommended times.

10 Dec 2010

Alliance of Specialty Medicine calls for new, permanent Medicare reimbursement formula

The Alliance of Specialty Medicine (Alliance) today called on Congress to permanently fix Medicare's Sustainable Growth Rate (SGR) after lawmakers once again passed a temporary fix, thereby postponing unprecedented reimbursement cuts to Medicare doctors until 2012.

10 Dec 2010

STENTYS initiates international APPOSITION III self-apposing stent study in AMI patients

STENTYS S.A., which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today that it has begun the international APPOSITION III study of its self-apposing stent, with 50 patients already enrolled out of a total of 500. The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.

10 Dec 2010

Harvard Bioscience files two major patents in regenerative medicine

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.

From Harvard Bioscience 10 Dec 2010

Prometheus, UCLA collaborate to identify biological markers of mucosal healing in IBD

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and The Regents of the University of California, Los Angeles campus, today announced the execution of an exclusive research agreement that will focus on the identification of biological markers of mucosal healing in patients with Inflammatory Bowel Disease (IBD). The research will be led by Dr. Jonathan Braun, Chair of the Department of Pathology and Laboratory Medicine and a professor of molecular and medical pharmacology, UCLA David Geffen School of Medicine.

10 Dec 2010

Medicine News and Research

Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer trial

EU, India leaders meet to discuss trade deal, some concerned deal will jeopardize drug access in developing countries

Denosumab delays skeletal-related side effects in patients with breast cancer and bone metastases

Cesarean-section deliveries may lead to degenerative back disease

Mayo clinic creates new computerized radiation tracking system

Genetic changes in HDAC9 gene may modulate onset of ER positive breast cancer and its recurrence

Depression drug appears effective in reducing pain associated with breast cancer treatment

New challenges to FDA's 'no risk' classification of mercury fillings

Research roundup: For-profit hospitals' readmission rate, containing self-referrals, children's dental health, revisiting McAllen

Deals, expansions and ACOs mark hospital sector activity

Stroke falls from third to fourth leading cause of death

Weightlifting may help prevent lymphedema following breast cancer treatment

Ipilimumab in combination with paclitaxel/carboplatin for stage IIIb/IV NSCLC shows superior results

HRT with estrogen alone may reduce risk of breast cancer: Study

First Edition: December 10, 2010

Process of activating helicopter EMS delays treatment for heart attacks beyond recommended times

Alliance of Specialty Medicine calls for new, permanent Medicare reimbursement formula

STENTYS initiates international APPOSITION III self-apposing stent study in AMI patients

Harvard Bioscience files two major patents in regenerative medicine

Prometheus, UCLA collaborate to identify biological markers of mucosal healing in IBD

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News